News Releases

*** This is a test sample for BUSINESS WIRE quarterly results release style. It will need to be removed before the site is set to live. *** Revenues of $4.7 billion Free cash flow of $0.6 billion Revenues of $4.7 billion Revenues of $4.7 billion GAAP diluted loss per share of $0.24 Non-GAAP diluted

December 11, 2025

*** This is a test sample for PRNewswire quarterly results release style. It will need to be removed before the site is set to live. *** DIVISIONR (valbenazine) Second Quarter Net Product Sales of $96.9 Million with Approximately 16,700 TRx DIVISION? (elagolix), the First FDA-Approved Oral

December 3, 2025